Grove Bank & Trust’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $581K | Buy |
1,107
+297
| +37% | +$156K | 0.07% | 157 |
|
|
2025
Q1 | $514K | Buy |
810
+767
| +1,784% | +$486K | 0.07% | 161 |
|
|
2024
Q4 | $30.6K | Buy |
43
+8
| +23% | +$5.7K | ﹤0.01% | 410 |
|
|
2024
Q3 | $36.8K | Buy |
35
+8
| +30% | +$8.41K | 0.01% | 387 |
|
|
2024
Q2 | $28.4K | Hold |
27
| – | – | ﹤0.01% | 399 |
|
|
2024
Q1 | $26K | Hold |
27
| – | – | ﹤0.01% | 426 |
|
|
2023
Q4 | $23.7K | Sell |
27
-42
| -61% | -$36.9K | ﹤0.01% | 423 |
|
|
2023
Q3 | $56.8K | Buy |
69
+15
| +28% | +$12.3K | 0.01% | 345 |
|
|
2023
Q2 | $38.8K | Sell |
54
-9
| -14% | -$6.47K | 0.01% | 392 |
|
|
2023
Q1 | $51.8K | Buy |
63
+7
| +13% | +$5.75K | 0.01% | 365 |
|
|
2022
Q4 | $40K | Buy |
+56
| New | +$40K | 0.01% | 393 |
|
|
2021
Q1 | – | Sell |
-1,020
| Closed | -$493K | – | 215 |
|
|
2020
Q4 | $493K | Buy |
1,020
+21
| +2% | +$10.2K | 0.13% | 132 |
|
|
2020
Q3 | $559K | Buy |
999
+151
| +18% | +$84.5K | 0.17% | 113 |
|
|
2020
Q2 | $529K | Buy |
848
+276
| +48% | +$172K | 0.17% | 113 |
|
|
2020
Q1 | $279K | Buy |
+572
| New | +$279K | 0.11% | 141 |
|
|
2017
Q4 | – | Sell |
-29
| Closed | -$13K | – | 558 |
|
|
2017
Q3 | $13K | Sell |
29
-16
| -36% | -$7.17K | 0.01% | 438 |
|
|
2017
Q2 | $22K | Buy |
45
+29
| +181% | +$14.2K | 0.01% | 367 |
|
|
2017
Q1 | $6K | Hold |
16
| – | – | ﹤0.01% | 403 |
|
|
2016
Q4 | $6K | Buy |
+16
| New | +$6K | ﹤0.01% | 441 |
|